Globe Life (GL) Q2 2024 earnings summary

Executive summary

• Net income for Q2 2024 was $258 million ($2.83/share), up 20% from $215 million ($2.24/share) a year ago; net operating income rose 14% to $271 million ($2.97/share).

• Net income for the six months ended June 30, 2024 increased 17% to $513 million, with diluted EPS up 22% to $5.51 year-over-year.

• Book value per share increased 40% to $58.06; excluding AOCI, up 14% to $82.38.

• An independent audit committee review found no evidence supporting short seller allegations of financial misconduct; no restatements or adjustments required.

• The company is cooperating with ongoing SEC and DOJ inquiries, with no claims asserted or indications of intent to do so.

Financial highlights

• Total premium revenue increased 5% year-over-year to $1.17 billion in Q2 and $2.31 billion for the first half of 2024; life premium up 4% and health premium up 6%.

• Net investment income rose 10% year-over-year to $568 million for H1 2024, driven by higher yields and asset growth.

• Life underwriting margin up 8% to $320 million in Q2; health underwriting margin up 12% to $37 million for Family Heritage.

• Administrative expenses were $82 million in Q2, up 9% year-over-year, representing 7% of premium.

• Shareholder returns in Q2 included $314 million in share repurchases and $23 million in dividends, totaling $337 million returned.

Outlook and guidance

• Full-year 2024 net operating EPS guidance raised to $11.80–$12.10, representing 12% growth at midpoint.

• Life premium revenue expected to grow 4.5%–5%; life underwriting margin to grow 9%–10% with margin as a percent of premium at 39%–41%.

• Health premium revenue projected to grow 6.5%–7%; health underwriting margin to grow 1%–2%.

• Net investment income expected to grow 7%–8% for the year.

• Share repurchases for 2024 anticipated at $750–$770 million, with $350–$370 million from excess cash flows and $400 million from additional capital.